Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2026-02-19 @ 2:47 PM
Study NCT ID:
NCT05399550
Status:
WITHDRAWN
Last Update Posted:
2023-08-07
First Post:
2022-05-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain Edema
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-17
Completion Date Type:
ACTUAL
First Submit Date:
2022-05-27
First Submit QC Date:
None
Study First Post Date:
2022-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-03
Last Update Post Date:
2023-08-07
Last Update Post Date Type:
ACTUAL